E-learningNews & eventsSpeakersPartners
Sign in
Sign in
Social media
Main pages
  • News & events
  • Speakers
  • Partners
  • Reviews
E-learning
  • Courses
  • Lectures
Corporate website
  • Sona Group

Contacts

  • info@sona-pharm.eu
  • Business days 9:00-17:00 EET
  • +372 505 9699
  • Ahtri 6, Tallinn, 10151, Estonia

Sona Group unites a network of independent pharmaceutical and healthcare companies operating in research, manufacturing and continued medical education.

This website is intended for informational and corporate communication purposes only and is not a substitute for medical advice.

© 2026 Sona Academy®. All rights reserved.

··Site map
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
  • Legal Notice
  • Professional Medical Disclaimer
  • Data Collection and Privacy Disclaimer
  1. Home
  2. /
  3. All courses
  4. /
  5. Gene mutations and polymorphisms — a path to personalised treatment protocols.
  6. /
  7. Pharmacogenomics of Embryology and Endometrium in ART
Reproductive healthLecture

Pharmacogenomics of Embryology and Endometrium in ART

An expanded lecture by Vitalii Radko, MD PhD, Head of Department at Mother and Child Medical Centre (Kyiv), on applying pharmacogenomics beyond FSH/LH receptors — in complex ART clinical cases. The 180-gene infertility panel, ESR1/ESR2 polymorphisms in oocyte donors (Belen Lledó, Bernabeu Institute), the ESR2 rs4986938 marker for idiopathic thin endometrium, poor blastulation in patients under 40 and calcium ionophore in a selected cohort, the WEE2 gene — recurrent ICSI fertilisation failures, true empty follicle syndrome via LHCGR and zona pellucida proteins ZP1-3.

Vitaliy Radko
Vitaliy Radko
Audio: UASubtitles: EN · UA · RU36 min
Vitaliy Radko

Vitaliy Radko

MD, PhD

Head doctor at the «Mother and Child» Medical Center in Kyiv. Candidate of Medical Sciences (PhD), obstetrician-gynecologist, reproductive specialist and gynecologist-endocrinologist.

Ukraine

Pharmacogenomics in ART does not end at ovarian stimulation. The lecture shifts focus to embryology, the endometrium, and the cases where classical protocols fail for reasons hidden in the genome — from oocyte donors to total fertilization failure after ICSI.

ESR1/ESR2 polymorphisms and endometrial receptivity

ESR1 and ESR2 polymorphisms in patients and oocyte donors correlate with embryo quality and cycle clinical efficacy. A particular clinical interest is genetic predictors of idiopathic thin endometrium, which open a new diagnostic class for patients previously catalogued as «cause unknown».

Calcium ionophore: indications and limitations

Systematically poor blastulation in younger patients is a distinct clinical problem. Calcium ionophore has a role as targeted therapy — in a selected cohort where artificial activation compensates for insufficient calcium signalling after fusion. It is not a «universal solution». The literature is mixed: some studies show benefit in specific indications, others show no effect in general populations. The speaker's own pilot data support efficacy when poor blastulation is combined with ESR polymorphisms.

WEE2 and total ICSI failure

The WEE2 gene encodes a kinase required for exit from meiotic arrest after sperm entry. WEE2 mutations are one of the identified causes of total fertilization failure after ICSI when all other parameters are normal. In such patients, repeat ICSI without intervention is futile — the diagnosis redirects them toward oocyte donation or experimental approaches.

Empty follicle syndrome: true vs pseudo

Empty follicle syndrome is a real genetic phenomenon, but it must be distinguished from a pseudo-form caused by clinical errors (incorrect trigger, timing, mismatched post-trigger marker assessment). Only the true syndrome is a genetic pathology. The LH/hCG receptor and zona pellucida proteins, critical for the fertilization process, play a role here. Differentiation allows for the correct strategy — from protocol correction to a change of clinical route.

Expanded pre-cycle workup

Modern commercial panels cover about 180 infertility genes, a portion of which are already clinically validated. The approach is not «test everyone» but «select tests by clear clinical triggers»: failed ICSI, thin endometrium, poor blastulation, repeated embryo loss. A properly built pre-cycle workup turns «cause unknown» into a manageable clinical category.

Topics covered

  • ESR1/ESR2 polymorphisms in patients and oocyte donors
  • Genetic predictors of idiopathic thin endometrium
  • Calcium ionophore: indications, limitations, ongoing debate
  • The WEE2 gene and total ICSI fertilization failure
  • True vs pseudo empty follicle syndrome
  • Zona pellucida proteins in the fertilization process
  • LH/hCG receptor and genetic causes of failure
  • Expanded infertility gene panel in practice
  • Pre-cycle workup driven by clinical triggers
  • Clinical algorithm for ICSI failure and poor blastulation
Course

Gene mutations and polymorphisms — a path to personalised treatment protocols.

View course

Related lectures

  • Personalizing LH supplementation in female infertility: which patients may benefitLH in reproductive medicine: personalized approaches in female and male infertility.
  • Personalizing gonadotropin treatment in male infertility: how APHRODITE may helpLH in reproductive medicine: personalized approaches in female and male infertility.
  • Why euploid embryos fail to implant?Why do euploid embryos fail to implant.
Vitaliy Radko

Vitaliy Radko

Head doctor at the «Mother and Child» Medical Center in Kyiv. Candidate of Medical Sciences (PhD), obstetrician-gynecologist, reproductive specialist and gynecologist-endocrinologist.

Author of the lecture "Pharmacogenomics of Embryology and Endometrium in ART"